CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 18 filers reported holding CALLIDITAS THERAPEUTICS AB in Q3 2023. The put-call ratio across all filers is 10.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $487,323 | +13.1% | 26,688 | -1.9% | 0.30% | +20.2% |
| Q2 2023 | $431,053 | -35.3% | 27,214 | -2.1% | 0.25% | -40.4% |
| Q1 2023 | $666,246 | +49.0% | 27,795 | +5.6% | 0.42% | +41.0% |
| Q4 2022 | $447,253 | +2.6% | 26,309 | -8.5% | 0.30% | -3.3% |
| Q3 2022 | $436,000 | -14.7% | 28,742 | -0.1% | 0.30% | -10.8% |
| Q2 2022 | $511,000 | -7.3% | 28,763 | +0.0% | 0.34% | +14.4% |
| Q1 2022 | $551,000 | -18.4% | 28,762 | +5.5% | 0.30% | -10.5% |
| Q4 2021 | $675,000 | +12.1% | 27,267 | -2.0% | 0.33% | +7.1% |
| Q3 2021 | $602,000 | +28.6% | 27,836 | +75.2% | 0.31% | +32.2% |
| Q2 2021 | $468,000 | – | 15,890 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 200,000 | $6,724,000 | 2.33% |
| BVF INC/IL | 750,000 | $25,493,000 | 1.00% |
| Logos Global Management LP | 300,000 | $10,086,000 | 0.86% |
| Vivo Capital, LLC | 311,030 | $10,457,000 | 0.47% |
| HHLR ADVISORS, LTD. | 1,047,687 | $35,611,000 | 0.28% |
| Pentwater Capital Management LP | 50,000 | $1,681,000 | 0.02% |
| Point72 Asset Management, L.P. | 102,748 | $3,454,000 | 0.02% |
| DEUTSCHE BANK AG\ | 70,236 | $2,361,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 20,484 | $696,000 | 0.00% |
| JANE STREET GROUP, LLC | 7,557 | $256,000 | 0.00% |